Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation

Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation

Aim. To study the frequency of prescribing antithrombotic agents in patients with non-valvular atrial fibrillation (AF) who were hospitalized in the cardiology department of a multidisciplinary hospital.Material and methods. A retrospective one-time study of medical records of 765 patients with non-...

Full description

Bibliographic Details
Main Authors:	V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
Format:	Article
Language:	English
Published:	Столичная издательская компания 2019-03-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	atrial fibrillation thromboembolic complications pharmacoepidemiologic study antithrombotic therapy
Online Access:	https://www.rpcardio.online/jour/article/view/1858

Similar Items

ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY)
by: V. I. Petrov, et al.
Published: (2015-09-01)

Changes in Prescribing Antithrombotic Therapy in Patients with Atrial Fibrillation in the Multidisciplinary Hospital in Volgograd from 2012 to 2020
by: A. S. Gerasimenko, et al.
Published: (2022-01-01)

Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis)
by: O. V. Reshetko, et al.
Published: (2020-11-01)

RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE
by: I. V. Grajfer, et al.
Published: (2015-12-01)

APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
by: E. A. Ushkalova, et al.
Published: (2017-05-01)

The quality of prior antithrombotic therapy and the severity of ischemic stroke in atrial fibrillation
by: L. A. Geraskina, et al.
Published: (2020-10-01)

ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
by: A. Y. Rychkov, et al.
Published: (2016-01-01)

Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?
by: Yutao Guo, et al.
Published: (2010-05-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES
by: Ya. P. Dovgalevskiy, et al.
Published: (2016-01-01)

PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION
by: N. V. Mikheeva, et al.
Published: (2015-09-01)

The antithrombotic therapy of atrial fibrillation in patients with coronary heart disease
by: Olga L. Bockeria, et al.
Published: (2018-11-01)

Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
by: Abdelmoniem Moustafa, et al.
Published: (2019-10-01)

COMBINED ANTITHROMBOTIC THERAPY IN CASE OF PLANNED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ATRIAL FIBRILLATION IN ACTUAL CLINICAL PRACTICE
by: N. Yu. Khorkova, et al.
Published: (2018-12-01)

Post‐Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation
by: Shin‐Yi Lin, et al.
Published: (2022-03-01)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
by: Leonardo De Luca, et al.
Published: (2022-01-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
by: M. Yu. Gilyarov
Published: (2015-12-01)

Changes in prescribing antithrombotic therapy in patients with atrial fibrillation and myocardial infarction in 2016-2019
by: K. G. Pereverzeva, et al.
Published: (2020-08-01)

The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation
by: Jiayu Wang, et al.
Published: (2019-04-01)

Antithrombotic therapy and its impact on prognosis in patients with atrial fibrillation and myocardial infarction. Long-term observation results
by: Mariia V. Soloveva, et al.
Published: (2021-10-01)

Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
by: Yongqiang Fan, et al.
Published: (2022-02-01)

PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION
by: V. A. Sulimov, et al.
Published: (2016-01-01)

Safety and efficacy of dual versus triple antithrombotic therapy in Patients with atrial fibrillation undergoing percutaneous coronary intervention: a meta-analysis
by: Abdelmoniem Moustafa, et al.
Published: (2020-10-01)

RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov
Published: (2015-12-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

Antithrombotic alternatives for stroke prevention in atrial fibrillation: critical differences and remaining questions
by: James S Kalus
Published: (2013-04-01)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
by: Wilbert Bor, et al.
Published: (2020-06-01)

Fact-finding survey of antithrombotic treatment for prevention of cerebral and systemic thromboembolism in patients with non-valvular atrial fibrillation in 9 countries of the Asia-Pacific region
by: Satoshi Ogawa, et al.
Published: (2012-02-01)

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
by: So-Ryoung Lee, et al.
Published: (2022-08-01)

Triple Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Atrial Fibrillation – Balancing Risks and Benefits
by: Alexandru DEACONU, et al.
Published: (2021-03-01)

Antithrombotic Strategies in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systemic Review and Network Meta-Analysis of Randomized Controlled Trials
by: Su-Kiat Chua, et al.
Published: (2020-04-01)

ANTITHROMBOTIC THERAPY IN PATIENTS WITH METABOLIC SYNDROME AFTER ABDOMINAL DELIVERY
by: A. V. Khromylev, et al.
Published: (2016-10-01)

Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Felice Gragnano, et al.
Published: (2023-12-01)

Antithrombotic strategy in cancer patients comorbid with acute coronary syndrome and atrial fibrillation
by: Tianbo Wang, et al.
Published: (2023-12-01)

Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
by: A. S. Gerasimenko, et al.
Published: (2021-05-01)

Prior Antithrombotic Therapy Is Associated With Cerebral Microbleeds in Ischemic Stroke Patients With Atrial Fibrillation and/or Rheumatic Heart Disease
by: Yajun Cheng, et al.
Published: (2019-01-01)

Use of the CHADS2 risk score to guide antithrombotic treatment in patients with atrial fibrillation - room for improvement
by: Swiss Medical Weekly
Published: (2010-02-01)

The Management of Combined Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Particularly Complex Challenge, Especially in the Elderly
by: Leonardo Bencivenga, et al.
Published: (2018-07-01)

Managing antithrombotic treatment in a patient with atrial fibrillation and coronary stent with transient neurological symptoms in cerebral amyloid angiopathy
by: Julie Ravn, et al.
Published: (2022-12-01)

Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation
by: L. N. Uddin, et al.
Published: (2019-07-01)

Poor outcomes associated with antithrombotic undertreatment in patients with atrial fibrillation attending Gondar University Hospital: a retrospective cohort study
by: Eyob Alemayehu Gebreyohannes, et al.
Published: (2018-09-01)